Correlation between MMP-3, TIMP-3 expression and neuronal apoptosis after ischemia-reperfusion injury in rates

American Journal of Immunology

Volumn 3, Issue 2, 2007, Pages 25-30

  Zi, Xiaohong ^a   Mutasem, Abuhamed ^a   Yuan, Yi ^a   Xu, Haiqing ^a   Lei, Lifang ^a   Guo, Ke ^a   Yang, Qidong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Ischemica reperfusion injury; Matrix metalloproteinase; Neuronal apoptosis; Tissue inhibitors of matrix metalloproteinase

Indexed keywords

ESCIN; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; PROTEIN BCL 2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; HISTOPATHOLOGY; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPATHOLOGY; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 38749121330     PISSN: 1553619X     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajisp.2007.25.30     Document Type: Article

References (20)

1. Raoul C, Pettmann B and Henderson CE, 2000.Active killing of neurons during development-and following stress: a role for p75 (NTR) and Fas? Curr Opin, Neurobiol, 10:111-117.
2. Cheema ZF, Wade SB and Sata M, 1999. Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J Neurosci, 19:1754
3. Levy DE, Brott TG, Haley EC Jr, Marler JR, Sheppard GL, Barsan W and Broderick JP, 1994. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke. 25:291-297
4. Del Zoppo GJ, Copeland BR, Anderchek K, Hacke W and Koziol JA. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction, 1990. Stroke, 21:596-601.
5. Schlondorff J and Blobel CP, 1999. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Science, 112:3603-3617.
6. Woessner JF, 1998. The matrix metalloproteinase family. In: Parks WC, Mecham RP, eds. Matrix Metalloproteinases. San Diego, Calif. Academic Press, 1-13.
7. Powell WC, Fingleton B and Wilson CL, 1999. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol, 9:1441-1447.
8. Bond M, Murphy G, Bennett MR, et al, 2002. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain- dependent type II apoptotic pathway. J Biol Chem, 277 (16): 13787-13795.
9. Longa EZ, Weinstein PR, Carlson S and Cummins R, 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20: 84-91.
10. Jaworski DM, 2000. Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury. Glia, 30:199-208.
11. Rathke-Hartlieb S, Budde P, Ewert S, Schlomann U, Staege MS, Jockusch H, Bartsch JW and Frey. J, 2000. Elevated expression of membrane type I metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system. FEBS Lett, 481:227-234.
12. Ashkenazi A and Dixit VM, 1998. Death receptors: signaling and modulation. Science, 281:1305-1308.
13. Graham SH and Chen J, 2001. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab, 21:99-109.
14. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ and Murphy G, 1998. TNF-converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435:39-44.
15. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knauper V, Docherty AJ and Murphy G, 2000. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett, 473:275-279.
16. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM, 1999. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epitnelial cell apoptosis. Curr Biol, 9:1441-144.
17. Matsuno H, Yudoh K, Watanabe Y, Nakazawa F, Aono H and Kimura T, 2001. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J Rheumatol, 28:22-28.
18. Smith MR, Kung H, Durum SK, Colburn NH and Sun Y, 1997. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine, 9:770-780
19. Martin-Villalba A, Herr I, Jeremias I, Halne M, Brandt R, Vogel J, Schenkel J, Herdegen T and Debatin KM, 1999. CD95 ligand (Fas- L/APO-IL) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci, 19:3809-3817
20. Wetzel M, Rosenberg-GA and Cunningham LA, 2003. Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur J Neuroscience, 18: 1050-1060.